Saffron Walden, Essex, South East, United Kingdom Hybrid / WFH Options
EMBL-EBI
the reach and utility of sequence data. Your role This is an exciting opportunity to make a significant contribution to development of a new open-source Perturbation Catalogue for harmonised and curated human gene (e.g. CRISPR), variant (e.g. MAVE), and expression (e.g. Perturb-seq) data. This project is … funded through the Open Targets consortium, an innovative public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation. The new resource will help to address a fundamental need in the scientific and drug discovery community for a comprehensive resource to understand the … offering enhanced statistical power and the capability to work with disease subtypes at a finer granularity. The Perturbation Catalogue will deliver rich community standards, open-source harmonisation and meta-analysis software, gold standard machine learning ready datasets, and a highly customisable public cloud platform with distributed data warehousing more »
provide assistance in fixing issues. Preferred Skillset Working experience in RDK-V. Experience working in Agile mode. In Yocto and familiar with working on opensource community. Business communication skills – verbal & written. more »
and responsibilities. mentoring, coaching team members. business communication skills – verbal & written. Preferred Skillset experience in RDK-V. in Yocto and familiar with working on opensource community. more »
coaching team members. Excellent business communication skills – verbal & written. Preferred Skillset Working experience in RDK-V. Knowledge in Yocto and familiar with working on opensource community. more »
the reach and utility of sequence data. Your role This is an exciting opportunity to make a significant contribution to development of a new open-source Perturbation Catalogue for harmonised and curated human gene (e.g. CRISPR), variant (e.g. MAVE), and expression (e.g. Perturb-seq) data. This project is … funded through the Open Targets consortium, an innovative public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation. The new resource will help to address a fundamental need in the scientific and drug discovery community for a comprehensive resource to understand the more »
